Xcout Intel
Immunis, Inc. competitors & alternatives
The 12 closest competitors and alternatives to Immunis, Inc. among biotechnology companies — ranked by similarity to what Immunis, Inc. actually does, not by market-cap band.
Subscribe to see Immunis, Inc.’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
About Immunis, Inc.
Immunis, Inc. is a private, clinical-stage biotechnology company founded in 2019 and headquartered in Irvine, California, pursuing novel secretome-based therapeutics for age-related diseases.
Immunis, Inc. at a glance
Immunis, Inc. is a biotechnology company headquartered in United States. It has raised at least $32.4M across the 2 funding rounds on record. Its most recent funding round raised $12M in May 2026. Xcout tracks 13 named people at Immunis, Inc., including Hans Keirstead (President).
Immunis, Inc. leadership
- Hans KeirsteadPresident
- Mark CabatoChief Business Officer
- Tom LaneChief Science Officer
- Hans S. KeirsteadChairman
- Mihaela (Mani) NistorVP of Regulatory and Clinical Compliance
- Erin CurryDirector of Medical Affairs
7 more named people on record for Immunis, Inc., with roles, board committees and tenure — see the full roster →
Immunis, Inc. funding rounds
At least $32.4M raised across the 2 rounds on record. Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| SEC Form D filing | $12M | — | |
| SEC Form D filing | $20.4M | — |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
Top 12 Immunis, Inc. competitors
Ranked by semantic similarity — how close each company is to Immunis, Inc. by what it does, using Xcout's live company graph. Click any company for its full profile, or its competitor set.
Similar biotechnology company
Secretome Therapeutics, Inc. is a biotechnology and holding company located in Texas, United States, operating in the drug pipeline and therapeutics sector.
Health & Life Sciences
Deciduous Therapeutics, Inc. is a biotechnology startup located in San Francisco, California, focused on developing novel therapeutics targeting aging and immune dysfunction.
Biotech
TECregen AG is a biotechnology company headquartered in Basel, Switzerland. The company is dedicated to advancing immuno-rejuvenation through the development of next-generation therapies designed to regenerate the thymus.
Similar biotechnology company
Autonomy Bio Inc. is a biotechnology company focused on developing human aging therapeutics aimed at extending healthspan and mitigating age-related decline. The company targets individuals seeking to maintain health and independence as they age.
Similar biotechnology company
Immunitas Therapeutics, Inc. is a US-based biotechnology company established in 2019 and headquartered in Waltham, Massachusetts. The company focuses on pioneering novel therapeutic treatments in immunology and oncology.
Biotech
Rejuvenate Bio, Inc. is a biotechnology company founded in 2019 and headquartered in San Diego, United States, specializing in innovative gene therapy applications.
Similar biotechnology company
U-Factor Life Science Co., Ltd. is a biotech startup pioneering stem cell-derived conditioned medium and supernatant for drug discovery and anti-aging applications.
Life Science
Angiocrine Bioscience, Inc. is a private, clinical-stage biotechnology company based in San Diego, California, that develops engineered endothelial cell therapies.
Similar biotechnology company
Ambros Therapeutics is a clinical-stage biotechnology company headquartered in Irvine, California, focused on the development of innovative therapeutics.
Biotech
Tr1X is a private, clinical-stage biotechnology company focused on developing regulatory T cell-based products for autoimmune and inflammatory diseases. The company aims to advance Tr1-based immunotherapies to address unmet medical needs and is headquartered in San Diego, California.
Life Sciences
Basilard BioTech, Inc. is a biotechnology company founded in 2019 to research and develop novel therapeutic technologies. Headquartered in Southern California, United States, the company operates within the life sciences sector.
Biotech
VitaSpring Biomedical Co. Ltd. specializes in pioneering pharmaceutical solutions derived from cellular medicine. It previously operated as Shemn Corp. before rebranding as VitaSpring Biomedical Co. Ltd. in February 2020. The company was established in 2016 and its main operations are based in Irvine, California.
Analyze another company
Search any company we track to see its competitive set.
Or describe a company
Paste a short paragraph describing a company or product — we'll find the most similar companies we track, scored 1–100.
See the full profile of Immunis, Inc. and its market
Funding, investors, tech stack, hiring signals, leadership and corporate events — for Immunis, Inc.and every competitor above — in one live dashboard.
Subscribe to Xcout Intel →